---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-21-296143"
form_type: "8-K"
ticker: "NERV"
cik: "0001598646"
company_name: "Minerva Neurosciences, Inc."
filed_at: "2021-10-12T23:59:59+00:00"
generated_at: "2026-06-28T21:28:42.939067+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Minerva Neurosciences promotes Geoff Race to President, Frederick Ahlholm to CFO; pre-NDA meeting planned

## Summary
- Geoff Race promoted to President effective Oct 11, 2021; he was EVP, CFO, and CBO.
- Frederick Ahlholm promoted to CFO effective Oct 11, 2021; previously SVP and CAO.
- Company plans to submit pre-NDA meeting request to FDA for roluperidone; potential NDA in H1 2022.
- Ahlholm's base salary increased from $373,890 to $400,000; Race's base salary remains at $442,293.

## SEC filing metadata
- accession: 0001193125-21-296143
- form_type: 8-K
- ticker: NERV
- cik: 0001598646
- company_name: Minerva Neurosciences, Inc.
- filed_at: 2021-10-12T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1598646/000119312521296143/0001193125-21-296143-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1598646/000119312521296143/d236669d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-21-296143
- JSON: https://secwatch.observer/filing/0001193125-21-296143.json
- Plain text: https://secwatch.observer/filing/0001193125-21-296143.txt

## Key facts
- Executive change
  Geoffrey Race was appointed as President at Minerva Neurosciences, Inc..
  - Action: appointed
  - Role: President
  source text: On October 11, 2021, Minerva Neurosciences, Inc. (the “Company”) announced the appointment of Geoffrey Race as the Company’s President, effective October 11, 2021.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1598646/000119312521296143/0001193125-21-296143-index.htm
- Executive change
  Frederick Ahlholm was appointed as Chief Financial Officer at Minerva Neurosciences, Inc..
  - Action: appointed
  - Role: Chief Financial Officer
  source text: On October 11, 2021, the Company announced the appointment of Frederick Ahlholm as the Company’s Chief Financial Officer (principal financial officer and principal accounting officer), effective October 11, 2021.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1598646/000119312521296143/0001193125-21-296143-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.